结直肠腺瘤及早期结直肠癌中西医结合诊治专家共识(2021)

2021-11-19 中国中西医结合学会消化内镜学专业委员会大肠早癌专家委员会 中医杂志

积极开展规范的结直肠腺瘤及早期结直肠癌筛查及诊疗对降低 我国结直肠癌发病率和死亡率至关重要。

中文标题:

结直肠腺瘤及早期结直肠癌中西医结合诊治专家共识(2021)

发布日期:

2021-11-19

简要介绍:

随着人们生活方式的改变,尤其是膳食结构的 改变,我国结直肠癌 (colorectal cancer, CRC) 的 发病率和死亡率逐年升高,发病率已跃居我国恶性 肿瘤的第 2 位,死亡率居第 5 位,近年来,随着诊疗技术的提升,我国的结直肠癌总体五年生存率 也有了很大的提高,但仍低于欧美及日韩等地区,其根源在于结直肠癌早期诊断率总体偏低, 在我国 I 期的结直肠癌诊断率为 13. 9%,大部分患 者确诊时已是中晚期。

相关资料下载:
[AttachmentFileName(sort=1, fileName=结直肠腺瘤及早期结直肠癌中西医结合诊治专家共识(2021).pdf)] GetToolGuiderByIdResponse(projectId=1, id=bafad1c0022ea5c9, title=结直肠腺瘤及早期结直肠癌中西医结合诊治专家共识(2021), enTitle=, guiderFrom=中医杂志, authorId=0, author=, summary=积极开展规范的结直肠腺瘤及早期结直肠癌筛查及诊疗对降低 我国结直肠癌发病率和死亡率至关重要。, cover=https://img.medsci.cn/20211129/1638152798567_5579292.png, journalId=0, articlesId=null, associationId=2156, associationName=中国中西医结合学会消化内镜学专业委员会大肠早癌专家委员会, associationIntro=中国中西医结合学会消化内镜学专业委员会大肠早癌专家委员会, copyright=0, guiderPublishedTime=Fri Nov 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="page" title="Page 2"> <div class="layoutArea"> <div class="column"> <p>随着人们生活方式的改变,尤其是膳食结构的 改变,我国结直肠癌 (colorectal cancer, CRC) 的 发病率和死亡率逐年升高,发病率已跃居我国恶性 肿瘤的第 2 位,死亡率居第 5 位,近年来,随着诊疗技术的提升,我国的结直肠癌总体五年生存率 也有了很大的提高,但仍低于欧美及日韩等地区,其根源在于结直肠癌早期诊断率总体偏低, 在我国 I 期的结直肠癌诊断率为 13. 9%,大部分患 者确诊时已是中晚期。</p> </div> </div> </div>, tagList=[TagDto(tagId=439, tagName=消化道肿瘤), TagDto(tagId=539, tagName=结直肠癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=539, guiderKeyword=结直肠癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2968, appHits=191, showAppHits=0, pcHits=966, showPcHits=2777, likes=1, shares=34, comments=4, approvalStatus=1, publishedTime=Mon Nov 29 11:34:00 CST 2021, publishedTimeString=2021-11-19, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Nov 29 10:26:57 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 01:02:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=结直肠腺瘤及早期结直肠癌中西医结合诊治专家共识(2021).pdf)])
结直肠腺瘤及早期结直肠癌中西医结合诊治专家共识(2021).pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1224762, encodeId=64c61224e62bf, content=好资源,一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718f2326921, createdName=1226084am31(暂无昵称), createdTime=Mon Jun 06 16:19:23 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218756, encodeId=b49f1218e5654, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7366517644, createdName=ms3000000409750808, createdTime=Wed May 11 15:31:06 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213762, encodeId=d1291213e62e6, content=非常好的资源,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Sat Apr 23 22:01:30 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207081, encodeId=77aa120e081ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:39:50 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
    2022-06-06 1226084am31(暂无昵称)

    好资源,一起学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1224762, encodeId=64c61224e62bf, content=好资源,一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718f2326921, createdName=1226084am31(暂无昵称), createdTime=Mon Jun 06 16:19:23 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218756, encodeId=b49f1218e5654, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7366517644, createdName=ms3000000409750808, createdTime=Wed May 11 15:31:06 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213762, encodeId=d1291213e62e6, content=非常好的资源,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Sat Apr 23 22:01:30 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207081, encodeId=77aa120e081ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:39:50 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
    2022-05-11 ms3000000409750808

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1224762, encodeId=64c61224e62bf, content=好资源,一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718f2326921, createdName=1226084am31(暂无昵称), createdTime=Mon Jun 06 16:19:23 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218756, encodeId=b49f1218e5654, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7366517644, createdName=ms3000000409750808, createdTime=Wed May 11 15:31:06 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213762, encodeId=d1291213e62e6, content=非常好的资源,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Sat Apr 23 22:01:30 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207081, encodeId=77aa120e081ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:39:50 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
    2022-04-23 ms3000000771933475

    非常好的资源,学习了!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1224762, encodeId=64c61224e62bf, content=好资源,一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718f2326921, createdName=1226084am31(暂无昵称), createdTime=Mon Jun 06 16:19:23 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218756, encodeId=b49f1218e5654, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7366517644, createdName=ms3000000409750808, createdTime=Wed May 11 15:31:06 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213762, encodeId=d1291213e62e6, content=非常好的资源,学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Sat Apr 23 22:01:30 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207081, encodeId=77aa120e081ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:39:50 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
    2022-03-30 56446_2968

    学习

    0

拓展阅读

2010 BSG 中高危人群结直肠癌筛查与监测指南

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2010-05-01

2010 结直肠癌肝转移诊断和综合治疗指南(V 2010)

中华医学会外科学分会 · 2010-06-01

2011 NICE 结直肠癌诊疗指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011NICE 结直肠癌高危人群(溃疡性结肠炎、克罗恩病、结直肠腺瘤患者)结肠镜监测指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-03-23

2011 规范结直肠癌术中缓释型氟尿嘧啶腹腔内化疗的专家共识

结直肠癌术中缓释型氟尿嘧啶腹腔内化疗共识专家组 · 2011-06-01

结直肠癌诊疗规范(2010年版)

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-12-20